{
    "ticker": "THMO",
    "name": "ThermoGenesis Holdings, Inc.",
    "description": "ThermoGenesis Holdings, Inc. is a pioneering company in the field of regenerative medicine, specializing in the development and commercialization of innovative products and services for the processing and storage of cellular therapies. Founded in 1986, the company has focused on addressing the increasing demand for high-quality stem cell and tissue-based therapies. ThermoGenesis offers a range of automated and manual systems for cell processing, as well as proprietary cell-based products that enhance the yield and viability of stem cells. Their flagship product, the AutoXpress (AXP) system, is designed to optimize the collection, processing, and storage of stem cells, enabling clinicians to harness the potential of regenerative medicine for various applications, including orthopedic, cardiovascular, and neurological conditions. The company is committed to advancing the field of cellular therapy through ongoing research and development, strategic partnerships, and an emphasis on quality and regulatory compliance. ThermoGenesis aims to improve patient outcomes by providing healthcare professionals with the tools they need to deliver effective therapies and contribute to the evolving landscape of regenerative medicine.",
    "industry": [
        "Biotechnology",
        "Medical Devices"
    ],
    "headquarters": "Rancho Cordova, California, USA",
    "founded": "1986",
    "website": "https://www.thermogenesis.com",
    "ceo": "Chris Xu",
    "social_media": {
        "twitter": "https://twitter.com/ThermoGenesis",
        "linkedin": "https://www.linkedin.com/company/thermogenesis-holdings-inc/"
    },
    "investor_relations": "https://www.thermogenesis.com/investor-relations",
    "key_executives": [
        {
            "name": "Chris Xu",
            "position": "CEO"
        },
        {
            "name": "Khalil A. S. Khatib",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Cell Processing Systems",
            "products": [
                "AutoXpress (AXP)",
                "SmartPReP 2"
            ]
        },
        {
            "category": "Cell Based Products",
            "products": [
                "CryoStor",
                "BioArchive"
            ]
        }
    ],
    "seo": {
        "meta_title": "ThermoGenesis Holdings, Inc. | Regenerative Medicine and Cell Therapy Solutions",
        "meta_description": "Explore ThermoGenesis Holdings, Inc., a leader in regenerative medicine offering innovative cell processing and storage solutions for cellular therapies.",
        "keywords": [
            "ThermoGenesis",
            "Regenerative Medicine",
            "Cell Therapy",
            "Stem Cells",
            "Medical Devices",
            "Cell Processing"
        ]
    },
    "faq": [
        {
            "question": "What does ThermoGenesis specialize in?",
            "answer": "ThermoGenesis specializes in regenerative medicine, focusing on cell processing and storage for cellular therapies."
        },
        {
            "question": "Who is the CEO of ThermoGenesis?",
            "answer": "Chris Xu is the CEO of ThermoGenesis Holdings, Inc."
        },
        {
            "question": "Where is ThermoGenesis headquartered?",
            "answer": "ThermoGenesis is headquartered in Rancho Cordova, California, USA."
        },
        {
            "question": "What are the main products of ThermoGenesis?",
            "answer": "ThermoGenesis's main products include the AutoXpress (AXP) system and various cryopreservation products."
        },
        {
            "question": "When was ThermoGenesis founded?",
            "answer": "ThermoGenesis was founded in 1986."
        }
    ],
    "competitors": [
        "ABT",
        "ZTS",
        "ILMN"
    ],
    "related_stocks": [
        "PFE",
        "JNJ",
        "MRNA",
        "GILD"
    ]
}